Welcome to our dedicated page for Xometry SEC filings (Ticker: XMTR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Xometry, Inc. filings document the public-company disclosures of an AI-native custom manufacturing marketplace with U.S. and international operations. Its 8-K reports commonly furnish quarterly and annual operating results, including marketplace growth drivers, gross profit trends, adjusted profitability measures, buyer and supplier network expansion, and enterprise engagement.
The filing record also includes material-event disclosures, material agreements, and capital-structure items involving Class A common stock. Proxy and annual meeting materials cover board composition, director elections, executive compensation, equity awards, advisory votes, auditor ratification, and related governance matters. These filings frame Xometry’s business around its marketplace, Thomasnet industrial sourcing platform, cloud-based services, real-time pricing, lead-time data, and custom manufacturing processes.
Xometry, Inc. (XMTR) director Randolph Altschuler reported that his spouse sold a total of 10,000 shares of Class A Common Stock on September 1, 2026 in open-market transactions. The shares are indirectly owned, as they are held by his spouse.
The sales were effected automatically pursuant to a Rule 10b-5 trading plan adopted by his spouse at least 90 days before the trades. The reported per‑share prices are weighted averages, with actual trade prices ranging from $89.70 to $92.16 across the three sale groups. After these transactions, Altschuler continues to hold Class A and Class B shares directly and additional Class A shares indirectly through family trusts.
Xometry, Inc. (XMTR) is the issuer for a planned resale of restricted common stock under Rule 144. UBS Financial Services Inc. filed on behalf of Cheryl Altschuler, related to director Randolph Altschuler, for the potential sale of 10,000 shares of common stock. The filing notes that 5,722 shares of common stock were sold in the prior three months.
Xometry, Inc. (XMTR) director Katharine Weymouth reported option exercises and share sales in late August 2026. She exercised stock options to acquire 10,000 shares of Class A Common Stock at an exercise price of $4.46 per share, split between August 28 and August 31, 2026. On each of those dates, she sold 5,000 shares in open-market transactions at weighted average prices of $94.3037 and $95.23 per share, respectively, for total reported sales of 10,000 shares. The options exercised were reported as fully vested, and the Rule 10b5-1 checkbox on the form is unchecked.
Xometry, Inc. (XMTR) has a notice of proposed sale of securities filed under Rule 144 for shares of its Class A Common Stock. Director Katherine Weymouth, through UBS Financial Services Inc., indicates an intention to sell 5,000 shares of Class A Common Stock of Xometry.
The notice also lists a prior transaction during the past three months, showing a sale involving 5,000 shares of Xometry stock on 08/28/2026, with an associated value of 471500. The planned sale references a cashless exercise of options and trading on NASDAQ.
Xometry, Inc. (XMTR) reported an insider sale by Chief Technology Officer Raghavan Vaidyanathan5,000 shares of Class A Common Stock in an open market or private transaction at a reported price of $96.765 per share. After this sale, he directly holds 135,777 shares of Xometry Class A Common Stock.
Xometry, Inc. (XMTR) received a Rule 144 notice covering potential sales of its Class A Common Stock for the account of director Katharine Weymouth. The notice lists 5,000 shares of Class A Common Stock to be sold through UBS Financial Services Inc. in connection with a cashless exercise of options coded as NQO on 08/28/2026. The notice also states that there are 55,848,262 shares of Class A Common Stock outstanding.
Xometry, Inc. (XMTR) has a notice filed on behalf of officer Vaidyanathan Raghavan for a potential sale of up to 5,000 shares of Class A common stock under Rule 144 through UBS Financial Services Inc. The shares have an aggregate market value of $481,250. Xometry reports 55,848,262 Class A shares outstanding. In the prior three months, Raghavan sold 1,866 shares for proceeds of $181,412. The notice also lists RSU-related securities of 2,280 shares dated July 1, 2026 and 2,720 shares dated July 1, 2025.
Xometry, Inc. (XMTR) director Randolph Altschuler reported an indirect disposition of Class A common stock through a bona fide gift. On 2026-08-20, the 2021 Tigers Trust transferred 85,582 Class A shares for no consideration to various trusts for which he is not the trustee or a beneficiary, leaving that trust with 0 shares. Following this, he reports direct holdings of 428,750 Class A shares and 1,475,311 Class B shares, plus additional indirect Class A holdings through his spouse and several family trusts.
Xometry, Inc. (XMTR) director Emily Rollins reported an option exercise and related share sales under a pre-established Rule 10b5-1 trading plan. She exercised options for 5,000 shares of Class A Common Stock at an exercise price of $12.32 per share and continued to hold 41,650 stock options afterward. On the same date, she sold an aggregate of 5,000 shares of Class A Common Stock in three weighted-average price transactions at per-share prices of $83.6073, $84.8270, and $85.4666, with actual trade prices occurring within the specific ranges described in the footnotes.
Xometry, Inc. (XMTR) has a planned secondary sale of shares by a director. Emily Rollins, a director of the company, has filed to potentially sell 5,000 shares of Class A common stock under Rule 144 through UBS Financial Services Inc. The shares are to be issued via exercise of stock options for cash and then may be sold on or after 08/19/2026 on NASDAQ.